Evofem Biosciences Total Liabilities 2013-2022 | EVFM
Evofem Biosciences total liabilities from 2013 to 2022. Total liabilities can be defined as the total value of all possible claims against the corporation.
Evofem Biosciences Annual Total Liabilities
(Millions of US $) |
| 2021 |
$142 |
| 2020 |
$109 |
| 2019 |
$13 |
| 2018 |
$27 |
| 2017 |
$104 |
| 2016 |
$1 |
| 2015 |
$16 |
| 2014 |
$12 |
| 2013 |
$2 |
| 2012 |
$2 |
Evofem Biosciences Quarterly Total Liabilities
(Millions of US $) |
| 2022-03-31 |
$159 |
| 2021-12-31 |
$142 |
| 2021-09-30 |
$126 |
| 2021-06-30 |
$100 |
| 2021-03-31 |
$107 |
| 2020-12-31 |
$109 |
| 2020-09-30 |
$72 |
| 2020-06-30 |
$67 |
| 2020-03-31 |
$15 |
| 2019-12-31 |
$13 |
| 2019-09-30 |
$15 |
| 2019-06-30 |
$19 |
| 2019-03-31 |
$32 |
| 2018-12-31 |
$27 |
| 2018-09-30 |
$25 |
| 2018-06-30 |
$21 |
| 2018-03-31 |
$27 |
| 2017-12-31 |
$104 |
| 2017-09-30 |
$1 |
| 2017-06-30 |
$2 |
| 2017-03-31 |
$2 |
| 2016-12-31 |
$1 |
| 2016-09-30 |
$1 |
| 2016-06-30 |
$7 |
| 2016-03-31 |
$7 |
| 2015-12-31 |
$16 |
| 2015-09-30 |
$20 |
| 2015-06-30 |
$15 |
| 2015-03-31 |
$13 |
| 2014-12-31 |
$12 |
| 2014-09-30 |
$0 |
| 2014-06-30 |
$0 |
| 2014-03-31 |
$0 |
| 2013-12-31 |
$2 |
| 2012-12-31 |
$2 |
| Sector |
Industry |
Market Cap |
Revenue |
| Medical |
Medical - Biomedical and Genetics |
$0.005B |
$0.008B |
|
Evofem Biosciences Inc. develops and anticipates commercializing products which support and promote women as the primary healthcare consumer. The company is identifying and developing new and novel products which specifically address unmet needs in the areas of sexual and reproductive health, the prevention of acquisition of sexually transmitted infections and products which address or promote general health and wellbeing. Evofem Biosciences Inc., formerly known as Neothetics Inc., is based in SAN DIEGO CA.
|
